|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1912973 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06800109.8 |
| Date of filing the European patent application | 2006-07-18 | |
| (97) | Date of publication of the European application | 2008-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2012-06-13 |
| (46) | Date of publication of the claims translation | 2012-08-27 |
| (86) | Number | PCT/US2006/027875 |
| Date | 2006-07-18 |
| (87) | Number | WO 2007/015870 |
| Date | 2007-02-08 |
| (30) | Number | Date | Country code |
| 701405 P | 2005-07-20 | US | |
| 716214 P | 2005-09-12 | US |
| (72) |
MANLEY, Paul, W., CH
SHIEH, Wen-Chung, US
SUTTON, Paul, Allen, US
KARPINSKI, Piotr, H., US
WU, Raeann, US
MONNIER, Stéphanie, FR
BROZIO, Jörg, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 4-Metil-N-[3-(4-metil-imidazol-1-il)-5-trifluormetil-fenil]3-(4-piridin-3-il-piridin-2-ilamino)-benzamido kristalinės formos |
| CRYSTALLINE FORMS OF 4-METHYL-N-[3-(4-METHYL-IMIDAZOL-1-YL)-5-TRIFLUOROMETHYL-PHENYL]3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-BENZAMIDE |
| Payment date | Validity (years) | Amount | |
| 2014-06-19 | 9 | 720.00 LTL |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2015-06-28 |